Alpha Tau Medical (DRTS) said Monday it received Medical Device Single Audit Program, or MDSAP, certification for its Jerusalem manufacturing facility.
MDSAP certification is recognized by regulatory authorities in Australia, Brazil, Canada, Japan, and the US, allowing medical device makers to meet international requirements through a single audit, the company said.
This certification can potentially support the company's plans to shorten the commercialization duration in participating markets for its alpha-radiation cancer therapy Alpha DaRT, it added.
Shares of Alpha Tau Medical were up nearly 1% in recent trading.
Price: 2.70, Change: +0.02, Percent Change: +0.75
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。